{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:07:18Z","timestamp":1790381238922,"version":"4.1.0"},"reference-count":89,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health (Ricerca Corrente 2024)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>While vitiligo is primarily caused by melanocyte deficiency or dysfunction, recent studies have revealed a notable prevalence of metabolic syndrome (MetS) among patients with vitiligo. This suggests shared pathogenic features between the two conditions. Individuals with vitiligo often exhibit variations in triglyceride levels, cholesterol, and blood pressure, which are also affected in MetS. Given the similarities in their underlying mechanisms, genetic factors, pro-inflammatory signalling pathways, and increased oxidative stress, this study aims to highlight the common traits between vitiligo and metabolic systemic disorders. Serum analyses confirmed increased low-density lipoprotein (LDL) levels in patients with vitiligo, compared to physiological values. In addition, we reported significant decreases in folate and vitamin D (Vit D) levels. Oxidative stress is one of the underlying causes of the development of metabolic syndromes and is related to the advancement of skin diseases. This study found high levels of inflammatory cytokines, such as interleukin-6 (IL-6) and chemokine 10 (CXCL10), which are markers of inflammation and disease progression. The accumulation of insulin growth factor binding proteins 5 (IGFBP5) and advanced glycation end products (AGEs) entailed in atherosclerosis and diabetes onset, respectively, were also disclosed in vitiligo. In addition, the blood-associated activity of the antioxidant enzymes catalase (Cat) and superoxide dismutase (SOD) was impaired. Moreover, the plasma fatty acid (FAs) profile analysis showed an alteration in composition and specific estimated activities of FAs biosynthetic enzymes resembling MetS development, resulting in an imbalance towards pro-inflammatory n6-series FAs. These results revealed a systemic metabolic alteration in vitiligo patients that could be considered a new target for developing a more effective therapeutic approach.<\/jats:p>","DOI":"10.3390\/ijms251810201","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T09:15:07Z","timestamp":1727082907000},"page":"10201","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Markers of Metabolic Abnormalities in Vitiligo Patients"],"prefix":"10.3390","volume":"25","author":[{"given":"Federica","family":"Papaccio","sequence":"first","affiliation":[{"name":"Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6613-2570","authenticated-orcid":false,"given":"Monica","family":"Ottaviani","sequence":"additional","affiliation":[{"name":"Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3046-3922","authenticated-orcid":false,"given":"Mauro","family":"Truglio","sequence":"additional","affiliation":[{"name":"Microbiology and Virology, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0669-1442","authenticated-orcid":false,"given":"Andrea","family":"D\u2019Arino","sequence":"additional","affiliation":[{"name":"Oncologic and Preventative Dermatology, San Gallicano Dermatological Institute, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Caputo","sequence":"additional","affiliation":[{"name":"Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Pacifico","sequence":"additional","affiliation":[{"name":"Clinical Dermatology, Phototherapy Unit, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Iacovelli","sequence":"additional","affiliation":[{"name":"Clinical Dermatology, Phototherapy Unit, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5575-9968","authenticated-orcid":false,"given":"Anna","family":"Di Nardo","sequence":"additional","affiliation":[{"name":"Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Picardo","sequence":"additional","affiliation":[{"name":"Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS, 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3883-5500","authenticated-orcid":false,"given":"Barbara","family":"Bellei","sequence":"additional","affiliation":[{"name":"Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo","volume":"386","author":"Ezzedine","year":"2015","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/1346-8138.15743","article-title":"Vitiligo: A Focus on Pathogenesis and its Therapeutic Implications","volume":"48","author":"Bergqvist","year":"2021","journal-title":"J. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"15011","DOI":"10.1038\/nrdp.2015.11","article-title":"Vitiligo","volume":"1","author":"Picardo","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_4","first-page":"216","article-title":"Vitiligo: The Psychosocial Effects","volume":"6","author":"Mason","year":"1997","journal-title":"MedSurg Nurs."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Lyu, C., and Sun, Y. (2022). Immunometabolism in the Pathogenesis of Vitiligo. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1055958"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/dth.12012","article-title":"Metabolic Syndrome in Vitiligo","volume":"25","author":"Pietrzak","year":"2012","journal-title":"Dermatol. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.abd.2021.09.008","article-title":"Update on the Pathogenesis of Vitiligo","volume":"97","author":"Marchioro","year":"2022","journal-title":"An. Bras. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Katz, E.L., and Harris, J.E. (2021). Translational Research in Vitiligo. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.624517"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-100919-023531","article-title":"Vitiligo: Mechanisms of Pathogenesis and Treatment","volume":"38","author":"Frisoli","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2340\/00015555-1141","article-title":"Insulin Resistance is Increased in Patients with Vitiligo","volume":"91","author":"Karadag","year":"2011","journal-title":"Acta Derm. Venereol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"D\u2019Arino, A., Picardo, M., Truglio, M., Pacifico, A., and Iacovelli, P. (2021). Metabolic Comorbidities in Vitiligo: A Brief Review and Report of New Data from a Single-Center Experience. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168820"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","article-title":"The Global Epidemic of the Metabolic Syndrome","volume":"20","author":"Saklayen","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ecl.2013.09.009","article-title":"Metabolic Syndrome","volume":"43","author":"Samson","year":"2014","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clindermatol.2017.09.005","article-title":"Psoriasis and the Metabolic Syndrome","volume":"36","author":"Gisondi","year":"2018","journal-title":"Clin. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Hao, Y., Zhu, Y., Zou, S., Zhou, P., Hu, Y., Zhao, Q., Gu, L., Zhang, H., Wang, Z., and Li, J. (2021). Metabolic Syndrome and Psoriasis: Mechanisms and Future Directions. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.711060"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4103\/ijd.ijd_418_23","article-title":"Psoriasis and its Association with Metabolic Syndrome","volume":"68","author":"Agarwal","year":"2023","journal-title":"Indian J. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.abd.2019.07.006","article-title":"Higher Incidence of Metabolic Syndrome Components in Vitiligo Patients: A Prospective Cross-Sectional Study","volume":"95","author":"Tanacan","year":"2020","journal-title":"An. Bras. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Hu, Z., and Wang, T. (2023). Beyond Skin White Spots: Vitiligo and Associated Comorbidities. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1072837"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e34772","DOI":"10.2196\/34772","article-title":"Vitiligo and Metabolic Syndrome: Systematic Review and Meta-Analysis","volume":"5","author":"Xia","year":"2022","journal-title":"JMIR Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Shen, C., Gao, J., Sheng, Y., Dou, J., Zhou, F., Zheng, X., Ko, R., Tang, X., Zhu, C., and Yin, X. (2016). Genetic Susceptibility to Vitiligo: GWAS Approaches for Identifying Vitiligo Susceptibility Genes and Loci. Front. Genet., 7.","DOI":"10.3389\/fgene.2016.00003"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1096\/fj.08-116327","article-title":"Evidence for the Ectopic Synthesis of Melanin in Human Adipose Tissue","volume":"23","author":"Randhawa","year":"2009","journal-title":"FASEB J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1467-789X.2010.00773.x","article-title":"Melanin and Melanogenesis in Adipose Tissue: Possible Mechanisms for Abating Oxidative Stress and Inflammation?","volume":"12","author":"Page","year":"2011","journal-title":"Obes. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1034\/j.1600-0749.2003.00087.x","article-title":"Alterations of Mitochondria in Peripheral Blood Mononuclear Cells of Vitiligo Patients","volume":"16","author":"Urbanelli","year":"2003","journal-title":"Pigment Cell Res."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Bellei, B., Pitisci, A., Ottaviani, M., Ludovici, M., Cota, C., Luzi, F., Dell\u2019Anna, M.L., and Picardo, M. (2013). Vitiligo: A Possible Model of Degenerative Diseases. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059782"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"13663","DOI":"10.1038\/s41598-017-13961-5","article-title":"Energetic Mitochondrial Failing in Vitiligo and Possible Rescue by Cardiolipin","volume":"7","author":"Ottaviani","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jid.2017.06.033","article-title":"Vitiligo Skin: Exploring the Dermal Compartment","volume":"138","author":"Kovacs","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Papaccio, F., Bellei, B., Ottaviani, M., D\u2019Arino, A., Truglio, M., Caputo, S., Cigliana, G., Sciuto, L., Migliano, E., and Pacifico, A. (2022). A Possible Modulator of Vitiligo Metabolic Impairment: Rethinking a PPAR\u03b3 Agonist. Cells, 11.","DOI":"10.3390\/cells11223583"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4274\/balkanmedj.2016.1005","article-title":"Increased Risk of Metabolic Syndrome in Patients with Vitiligo","volume":"34","year":"2017","journal-title":"Balk. Med. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e14803","DOI":"10.1111\/dth.14803","article-title":"Increased Risk of Subclinical Atherosclerosis and Metabolic Syndrome in Patients with Vitiligo: A Real Association or a Coincidence?","volume":"34","author":"Namazi","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jaad.2018.08.029","article-title":"Serum Homocysteine, Folate, and Vitamin B(12) Levels in Patients with Vitiligo and their Potential Roles as Disease Activity Biomarkers: A Systematic Review and Meta-Analysis","volume":"80","author":"Tsai","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3889\/oamjms.2017.066","article-title":"Correlation between Serum Homocysteine and Vitiligo Area Scoring Index","volume":"5","author":"Hasibuan","year":"2017","journal-title":"Open Access Maced J. Med. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Rehman, K., and Akash, M.S.H. (2016). Mechanisms of Inflammatory Responses and Development of Insulin Resistance: How are they Interlinked?. J. Biomed. Sci., 23.","DOI":"10.1186\/s12929-016-0303-y"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1034\/j.1600-0749.2002.1o049.x","article-title":"New Insights into the Pathogenesis of Vitiligo: Imbalance of Epidermal Cytokines at Sites of Lesions","volume":"15","author":"Moretti","year":"2002","journal-title":"Pigment Cell Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/pcmr.12667","article-title":"CXCL-10 and Interleukin-6 are Reliable Serum Markers for Vitiligo Activity: A Multicenter Cross-Sectional Study","volume":"31","author":"Abdallah","year":"2018","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jaad.2011.07.018","article-title":"Circulatory Levels of T-Cell Cytokines (Interleukin [IL]-2, IL-4, IL-17, and Transforming Growth Factor-\u0392) in Patients with Vitiligo","volume":"66","author":"Khan","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_36","first-page":"81","article-title":"Expression of IL-17 and COX2 Gene in Peripheral Blood Leukocytes of Vitiligo Patients","volume":"10","author":"Esmaeili","year":"2011","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1365-2230.2010.03972.x","article-title":"Role of Interleukin-17 in the Pathogenesis of Vitiligo","volume":"36","author":"Bassiouny","year":"2011","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1684\/ejd.2013.2023","article-title":"Interleukin 17, Interleukin 22 and FoxP3 Expression in Tissue and Serum of Non-Segmental Vitiligo: A Case- Controlled Study on Eighty-Four Patients","volume":"23","author":"Elela","year":"2013","journal-title":"Eur. J. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1365-2265.2004.02136.x","article-title":"Associations of Insulin-Like Growth Factors, Insulin-Like Growth Factor Binding Proteins and Acid-Labile Subunit with Coronary Heart Disease","volume":"61","author":"Fischer","year":"2004","journal-title":"Clin. Endocrinol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/10408399509527682","article-title":"Free Radicals and Antioxidants in Food and In Vivo: What they do and how they Work","volume":"35","author":"Halliwell","year":"1995","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejphar.2005.12.087","article-title":"Oxidant and Antioxidant Balance in the Airways and Airway Diseases","volume":"533","author":"Rahman","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1007\/s11095-013-1113-5","article-title":"Superoxide Dismutase Administration, a Potential Therapy Against Oxidative Stress Related Diseases: Several Routes of Supplementation and Proposal of an Original Mechanism of Action","volume":"30","author":"Carillon","year":"2013","journal-title":"Pharm. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ced.12950","article-title":"Meta-Analysis of the Association between Vitiligo and the Level of Superoxide Dismutase Or Malondialdehyde","volume":"42","author":"Shi","year":"2017","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/jocd.13499","article-title":"Does Oxidative Stress Correlate with Disease Activity and Severity in Vitiligo? An Analytical Study","volume":"20","author":"Mathachan","year":"2021","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Kassab, A., Khalij, Y., Ayed, Y., Dar-Odeh, N., Kokandi, A.A., Denguezli, M., and Youssef, M. (2023). Serum Inflammatory and Oxidative Stress Markers in Patients with Vitiligo. J. Clin. Med., 12.","DOI":"10.3390\/jcm12185861"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1038\/sj.jid.5700340","article-title":"Oxidative Stress in the Pathogenesis of Skin Disease","volume":"126","author":"Bickers","year":"2006","journal-title":"J. Investig. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Chang, W., and Ko, C. (2023). The Role of Oxidative Stress in Vitiligo: An Update on its Pathogenesis and Therapeutic Implications. Cells, 12.","DOI":"10.3390\/cells12060936"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00403-017-1746-z","article-title":"Oxidation Products are Increased in Patients Affected by Non-Segmental Generalized Vitiligo","volume":"309","author":"Vaccaro","year":"2017","journal-title":"Arch. Dermatol. Res."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Planas, A., Sim\u00f3-Servat, O., Hern\u00e1ndez, C., and Sim\u00f3, R. (2022). Advanced Glycations End Products in the Skin as Biomarkers of Cardiovascular Risk in Type 2 Diabetes. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23116234"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/13813455.2020.1797106","article-title":"Role of Advanced Glycation End Products and Insulin Resistance in Diabetic Nephropathy","volume":"129","author":"Parwani","year":"2023","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"560S","DOI":"10.1093\/ajcn\/70.3.560s","article-title":"Essential Fatty Acids in Health and Chronic Disease","volume":"70","author":"Simopoulos","year":"1999","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.ejcn.1601478","article-title":"Polyunsaturated Fatty Acids, Inflammation and Immunity","volume":"56","author":"Calder","year":"2002","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.plefa.2006.05.012","article-title":"Polyunsaturated Fatty Acids and Inflammation","volume":"75","author":"Calder","year":"2006","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Abdelmagid, S.A., Clarke, S.E., Nielsen, D.E., Badawi, A., El-Sohemy, A., Mutch, D.M., and Ma, D.W.L. (2015). Comprehensive Profiling of Plasma Fatty Acid Concentrations in Young Healthy Canadian Adults. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0116195"},{"key":"ref_55","first-page":"e45030","article-title":"Unveiling the Unseen Struggles: A Comprehensive Review of Vitiligo\u2019s Psychological, Social, and Quality of Life Impacts","volume":"15","author":"Salama","year":"2023","journal-title":"Cureus"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jcla.20442","article-title":"Increased Level of Serum Homocysteine in Vitiligo","volume":"25","author":"Singh","year":"2011","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jphotobiol.2015.04.005","article-title":"Serum Levels of Homocysteine, Folate and Vitamin B12 in Patients with Vitiligo before and After Treatment with Narrow Band Ultraviolet B Phototherapy and in a Group of Controls","volume":"148","author":"Cemil","year":"2015","journal-title":"J. Photochem. Photobiol. B."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.bbadis.2016.11.010","article-title":"Mitochondrial Dysfunction and Oxidative Stress in Metabolic Disorders\u2014A Step Towards Mitochondria Based Therapeutic Strategies","volume":"1863","author":"Bhatti","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.abd.2023.03.007","article-title":"Clinical Profile of Vitiligo Patients and Relationship with Immuno-Inflammatory Markers","volume":"99","author":"Mascarenhas","year":"2024","journal-title":"An. Bras. Dermatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.autrev.2016.01.004","article-title":"The Role of IL-17 in Vitiligo: A Review","volume":"15","author":"Singh","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5524566","DOI":"10.1155\/2021\/5524566","article-title":"Increased Circulatory Interleukin-17A Levels in Patients with Progressive and Leukotrichial Vitiligo","volume":"2021","author":"Le","year":"2021","journal-title":"Dermatol. Res. Pract."},{"key":"ref_62","first-page":"e208","article-title":"Interleukin-17 Level in Patients with Vitiligo: A Systematic Review and Meta-Analysis","volume":"61","author":"Acharya","year":"2020","journal-title":"Australas. J. Dermatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"635","DOI":"10.4103\/0019-5154.169136","article-title":"Plasma Levels of Interleukin-17, Interleukin-23, and Transforming Growth Factor-\u0392 in Sudanese Patients with Vitiligo: A Case-Control Study","volume":"60","author":"Osman","year":"2015","journal-title":"Indian J. Dermatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4103\/0378-6323.48427","article-title":"Determination of Oxidative Stress in Vitiligo by Measuring Superoxide Dismutase and Catalase Levels in Vitiliginous and Non-Vitiliginous Skin","volume":"75","author":"Sravani","year":"2009","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12291-010-0045-7","article-title":"Study of Oxidative Stress in Vitiligo","volume":"26","author":"Jain","year":"2011","journal-title":"Indian. J. Clin. Biochem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.gene.2013.11.055","article-title":"The Association of FOXO3A Gene Polymorphisms with Serum FOXO3A Levels and Oxidative Stress Markers in Vitiligo Patients","volume":"536","author":"Oner","year":"2014","journal-title":"Gene"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s40257-017-0298-5","article-title":"Vitiligo: An Update on Pathophysiology and Treatment Options","volume":"18","author":"Speeckaert","year":"2017","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2230.2004.01524.x","article-title":"Oxidant-Antioxidant Enzymes and Lipid Peroxidation in Generalized Vitiligo","volume":"29","author":"Koca","year":"2004","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00403-009-0964-4","article-title":"Circulatory Levels of Antioxidants and Lipid Peroxidation in Indian Patients with Generalized and Localized Vitiligo","volume":"301","author":"Khan","year":"2009","journal-title":"Arch. Dermatol. Res."},{"key":"ref_70","first-page":"167","article-title":"Update on the Genetics Characterization of Vitiligo","volume":"5","year":"2011","journal-title":"Int. J. Health Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jdermsci.2005.06.004","article-title":"The Genetic Concept of Vitiligo","volume":"39","author":"Zhang","year":"2005","journal-title":"J. Dermatol. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4103\/2229-5178.142493","article-title":"Increased Prevalence of Thyroid Dysfunction and Diabetes Mellitus in Indian Vitiligo Patients: A Case-Control Study","volume":"5","author":"Gopal","year":"2014","journal-title":"Indian Dermatol. Online J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/ijd.12148","article-title":"Prevalence of Vitiligo among Type 2 Diabetic Patients in an Iranian Population","volume":"53","author":"Zaji","year":"2014","journal-title":"Int. J. Dermatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4103\/ijd.IJD_360_16","article-title":"A Study of Vitiligo in Type 2 Diabetic Patients","volume":"62","author":"Raveendra","year":"2017","journal-title":"Indian J. Dermatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jaad.2019.06.022","article-title":"The Association between Vitiligo and Diabetes Mellitus: A Systematic Review and Meta-Analysis","volume":"81","author":"Chang","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Khalid, M., Petroianu, G., and Adem, A. (2022). Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives. Biomolecules, 12.","DOI":"10.3390\/biom12040542"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4196\/kjpp.2014.18.1.1","article-title":"Advanced Glycation End Products and Diabetic Complications","volume":"18","author":"Singh","year":"2014","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Lee, J., Yun, J., and Ko, S. (2022). Advanced Glycation End Products and their Effect on Vascular Complications in Type 2 Diabetes Mellitus. Nutrients, 14.","DOI":"10.3390\/nu14153086"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"5762395","DOI":"10.1155\/2020\/5762395","article-title":"Lipid-Induced Mechanisms of Metabolic Syndrome","volume":"2020","author":"Denisenko","year":"2020","journal-title":"J. Obes."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2017.08.002","article-title":"New Pro-Resolving N-3 Mediators Bridge Resolution of Infectious Inflammation to Tissue Regeneration","volume":"64","author":"Serhan","year":"2018","journal-title":"Mol. Aspects Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/bph.14587","article-title":"Lipid Mediators in Immune Regulation and Resolution","volume":"176","author":"Gilroy","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Lepretti, M., Martucciello, S., Burgos Aceves, M.A., Putti, R., and Lionetti, L. (2018). Omega-3 Fatty Acids and Insulin Resistance: Focus on the Regulation of Mitochondria and Endoplasmic Reticulum Stress. Nutrients, 10.","DOI":"10.3390\/nu10030350"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2018.02.012","article-title":"Omega-3 Fatty Acids in Obesity and Metabolic Syndrome: A Mechanistic Update","volume":"58","author":"Kalupahana","year":"2018","journal-title":"J. Nutr. Biochem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.numecd.2008.07.008","article-title":"Relationship between N-3 and N-6 Plasma Fatty Acid Levels and Insulin Resistance in Coronary Patients with and without Metabolic Syndrome","volume":"19","author":"Nigam","year":"2009","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.clnu.2013.03.001","article-title":"Plasma Fatty Acid Composition, Estimated Desaturase Activities, and their Relation with the Metabolic Syndrome in a Population at High Risk of Cardiovascular Disease","volume":"33","author":"Guerendiain","year":"2014","journal-title":"Clin. Nutr."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/acel.12344","article-title":"The Achilles\u2019 Heel of Senescent Cells: From Transcriptome to Senolytic Drugs","volume":"14","author":"Zhu","year":"2015","journal-title":"Aging Cell"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Revised Classification\/Nomenclature of Vitiligo and Related Issues: The Vitiligo Global Issues Consensus Conference","volume":"25","author":"Ezzedine","year":"2012","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jfda.2019.10.003","article-title":"Gas Chromatography-Mass Spectrometry-Based Analytical Strategies for Fatty Acid Analysis in Biological Samples","volume":"28","author":"Chiu","year":"2020","journal-title":"J. Food Drug Anal."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Lepoittevin, M., Blancart-Remaury, Q., Kerforne, T., Pellerin, L., Hauet, T., and Thuillier, R. (2023). Comparison between 5 Extractions Methods in either Plasma Or Serum to Determine the Optimal Extraction and Matrix Combination for Human Metabolomics. Cell. Mol. Biol. Lett., 28.","DOI":"10.1186\/s11658-023-00452-x"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/18\/10201\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:02:42Z","timestamp":1760112162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/18\/10201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":89,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["ijms251810201"],"URL":"https:\/\/doi.org\/10.3390\/ijms251810201","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]}}}